Scholars Central

Conference abstractPublished 3 Jul 2017

An introduction to Excellent Center for Drug Discovery (ECDD), the drug screening platform in Thailand

Authors: Suparerk Borwornpinyo

Mahidol University, Thailand

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Excellent Center for Drug Discovery (ECDD) was recently established in 2016 through collaboration between Faculties of Science and Faculty of Medicine Ramathibodi Hospital, Mahidol University and Thailand Center of Excellence for Life Sciences (TCELS). ECDD was setup as one of the most integrated and state-of-the-art platform for High-Throughput, High-Content Screening in Thailand and used to investigate effects of library of nucleotides (dsRNA, siRNA, shRNA), chemicals and natural compounds to discover potential drugs for important diseases associated with aging and infection and anti-cancer. There are two major objectives including (1) to discover drug candidates through screening of approved drugs, natural compounds, and synthetic molecules using induced pluripotent stem cells (iPS) or other cell-based models of human diseases; (2) to be a service center for standardized drug and toxicity screening. In addition, ECDD has prepared personnel and systems for compound management and multi-divisions for early drug development. ECDD opens for collaborative research and development with investigators from all sectors to lead and ensure the successful development of novel therapeutic innovations with high commercial promise to enhance the country’s competitiveness and place Thailand as a regional center for drug discovery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Suparerk Borwornpinyo”